isospaglumic acid has been researched along with Peripheral Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canta, A; Carozzi, VA; Cavaletti, G; Chiorazzi, A; Lapidus, RG; Slusher, BS; Wozniak, KM | 1 |
| Bzdega, T; Janczura, KJ; Lavin, KM; Madore, JC; Neale, JH; Olszewski, RT; Profaci, CP; Zuo, D | 1 |
1 review(s) available for isospaglumic acid and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.
Topics: Animals; Astrocytes; Brain Injuries; Dipeptides; Glutamate Carboxypeptidase II; Humans; Hyperalgesia; Neuralgia; Neuropeptides; Neurotransmitter Agents; Peripheral Nervous System Diseases; Protease Inhibitors; Schizophrenia; Substance-Related Disorders | 2011 |
1 other study(ies) available for isospaglumic acid and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.
Topics: Animals; Antineoplastic Agents; Body Weight; Carboxypeptidases; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Ganglia, Spinal; Glutamic Acid; Neuroprotective Agents; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Statistics, Nonparametric | 2010 |